Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly cut short Thursday when a drug executive collapsed during President Donald Trump's announcement of a deal with pharmaceutical companies to lower obesity drug prices.
Incident Details
President Trump was speaking alongside representatives from Eli Lilly and Novo Nordisk about an agreement to expand coverage and reduce costs for popular obesity treatments Zepbound and Wegovy. While Eli Lilly's CEO, David Ricks, was addressing the press, he suddenly noticed the executive to his right was unwell.
“Are you OK? Gordon, are you OK?” David Ricks asked.
The man who fainted was identified as Gordon Findlay, the global brand director for Novo Nordisk. Mehmet Oz, the Administrator for the Centers for Medicare & Medicaid Services, quickly responded as Findlay fell to his knees and collapsed.
Aftermath
- President Trump observed the situation closely.
- Press members were quickly escorted out of the room.
- Health and Human Services Secretary was present during the incident.
Summary
During a high-profile announcement to reduce drug prices, Gordon Findlay of Novo Nordisk collapsed, prompting immediate medical attention and an early end to the Oval Office event.
Would you like the summary to be more formal or conversational?